# First Tracks Biotherapeutics, Inc. (TRAX)

> Source: Nexqual · https://nexqual.com/TRAX · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, First Tracks Biotherapeutics, Inc. (TRAX), nexqual.com/TRAX" · informational, not investment advice.

**Price:** USD 36.04 (+5.60% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 34.13 · day 33.99–36.3 · 52w 14.72–49.91 · market cap $1.29B · NMS

## Key facts
- Analysts: Buy (mean 1.75 on a 1–5 scale) (12 analysts), mean target USD 72.5 (range 57–100).
- Total return with dividends: 1Y +89.7% vs S&P 500 +18.1%; 5Y +53.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.89, revenue estimate $0K.

## Analysts
Consensus Buy (mean 1.75 on a 1–5 scale), 12 analysts; mean target USD 72.5 (low 57, high 100).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | Canaccord Genuity | Target raised | Buy | $50 → $60 |
| 2026-10-13 | Evercore ISI Group | Target raised | Outperform | $65 → $70 |
| 2026-10-13 | Wells Fargo | Target raised | Overweight | $62 → $70 |
| 2026-09-30 | Canaccord Genuity | Initiated | Buy | $50 |
| 2026-09-18 | Evercore ISI Group | Initiated | Outperform | $65 |
| 2026-09-16 | Guggenheim | Initiated | Buy | $100 |
| 2026-09-03 | HC Wainwright & Co. | Reiterated | Buy | $57 |
| 2026-08-13 | Barclays | Target raised | Overweight | $48 → $65 |
| 2026-08-13 | Wedbush | Target raised | Outperform | $60 → $70 |
| 2026-08-13 | Piper Sandler | Target raised | Overweight | $54 → $95 |
| 2026-08-13 | HC Wainwright & Co. | Target raised | Buy | $44 → $57 |
| 2026-08-10 | UBS | Target raised | Buy | $45 → $65 |

## Total return (dividends reinvested)
|  | 1Y (from 2026-04-06) | 5Y (from 2026-04-06) |
|---|---|---|
| Total return | +89.7% | +53.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | — | — |
| Volatility (annualized) | 118.1% | 113.7% |
| Max drawdown | -39.7% (Apr 2026→Jun 2026) | -32.1% (Apr 2026→May 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/TRAX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt